Financial statements 3 City Pharm
Balance sheet data of 3 CITY PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 822 782,87 | 1 414 632,17 | 1 216 469,29 | 1 331 696,98 | 1 706 641,44 | 1 772 740,89 |
| A. Fixed assets | 64 810,61 | 459 926,19 | 456 423,41 | 453 900,81 | 452 167,65 | 450 506,25 |
| B. Current assets | 757 972,26 | 954 705,98 | 760 045,88 | 877 796,17 | 1 254 473,79 | 1 322 234,64 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 822 782,87 | 1 414 632,17 | 1 216 469,29 | 1 331 696,98 | 1 706 641,44 | 1 772 740,89 |
| A. Equity | -494 438,06 | -607 161,24 | -689 574,58 | -756 500,68 | -860 222,89 | -1 020 978,71 |
| B. Liabilities and provisions for liabilities | 1 317 220,93 | 2 021 793,41 | 1 906 043,87 | 2 088 197,66 | 2 566 864,33 | 2 793 719,60 |
| I. Long-term liabilities | 0,00 | 90 000,00 | 371 077,74 | 226 180,58 | 132 033,42 | 44 011,26 |
| II. Short-term liabilities | 1 317 220,93 | 1 894 878,13 | 1 491 025,51 | 1 801 696,92 | 2 391 005,40 | 2 685 858,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.